Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 17 genes, 30 drugs (DrugBank) and 62 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
2 | Amoebiasis 💬 19 genes, 29 drugs (DrugBank) and 63 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
3 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
4 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
5 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
CSF2RA [1] CSF2RA 💬
|
Mavrilimumab Mavrilimumab 💬
| Mavrilimumab | 041 [2] 41, 46 💬
|
6 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
CSF2RA [1] CSF2RA 💬
|
Molgramostim Molgramostim 💬
| Molgramostim | 097 [3] 97, 229, 299 💬
|
7 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
CSF2RA [1] CSF2RA 💬
|
Regramostim Regramostim 💬
| Regramostim | 229 [1] 229 💬
|
8 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
CSF2RA [1] CSF2RA 💬
|
Sargramostim Sargramostim 💬
| Sargramostim | 006 [7] 6 , 28, 60, 62, 96, 229, 285 💬
|
9 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
10 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
11 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CSF2RA [1] CSF2RA 💬
|
Mavrilimumab Mavrilimumab 💬
| Mavrilimumab | 041 [2] 41, 46 💬
|
12 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CSF2RA [1] CSF2RA 💬
|
Molgramostim Molgramostim 💬
| Molgramostim | 097 [3] 97, 229, 299 💬
|
13 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CSF2RA [1] CSF2RA 💬
|
Regramostim Regramostim 💬
| Regramostim | 229 [1] 229 💬
|
14 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CSF2RA [1] CSF2RA 💬
|
Sargramostim Sargramostim 💬
| Sargramostim | 006 [7] 6 , 28, 60, 62, 96, 229, 285 💬
|
15 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
16 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
17 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
18 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
CSF2RA [1] CSF2RA 💬
|
Mavrilimumab Mavrilimumab 💬
| Mavrilimumab | 041 [2] 41, 46 💬
|
19 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
CSF2RA [1] CSF2RA 💬
|
Molgramostim Molgramostim 💬
| Molgramostim | 097 [3] 97, 229, 299 💬
|
20 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
CSF2RA [1] CSF2RA 💬
|
Regramostim Regramostim 💬
| Regramostim | 229 [1] 229 💬
|
21 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
CSF2RA [1] CSF2RA 💬
|
Sargramostim Sargramostim 💬
| Sargramostim | 006 [7] 6 , 28, 60, 62, 96, 229, 285 💬
|
22 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
23 | Natural killer cell mediated cytotoxicity 💬 37 genes, 42 drugs (DrugBank) and 80 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
24 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA [1] CSF2RA 💬
|
Mavrilimumab Mavrilimumab 💬
| Mavrilimumab | 041 [2] 41, 46 💬
|
25 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA [1] CSF2RA 💬
|
Molgramostim Molgramostim 💬
| Molgramostim | 097 [3] 97, 229, 299 💬
|
26 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA [1] CSF2RA 💬
|
Regramostim Regramostim 💬
| Regramostim | 229 [1] 229 💬
|
27 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA [1] CSF2RA 💬
|
Sargramostim Sargramostim 💬
| Sargramostim | 006 [7] 6 , 28, 60, 62, 96, 229, 285 💬
|
28 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
29 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
30 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
31 | TNF signaling pathway 💬 18 genes, 56 drugs (DrugBank) and 84 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|
32 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases |
CSF2 [1] CSF2 💬
|
Otilimab Otilimab 💬
| Otilimab | 046 [1] 46 💬
|